Location · Aurora, CO
Clinical trials in Aurora, CO
269 recruiting studies have a site in Aurora, and 108 of them accept healthy volunteers.
269 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2/Phase 3
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Aurora, CO + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 1/Phase 2
Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
Mahzi Therapeutics
- Location
- Aurora, CO + 2 other US sites
- Eligibility basics
- Ages 2–25
- RecruitingPhase 3
Study of Ravulizumab in Pediatric Participants With Primary IgAN
Alexion Pharmaceuticals, Inc.
- Location
- Aurora, CO
- Eligibility basics
- Ages 2–18
- RecruitingPhase 2
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Healx Limited
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
RAPT Therapeutics, Inc., a member of the GSK plc group of companies
- Location
- Aurora, CO + 21 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingPhase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Aurora, CO + 10 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Edwards Lifesciences
- Location
- Aurora, CO + 20 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
ViiV Healthcare
- Location
- Aurora, CO + 32 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
GRIN Therapeutics, Inc.
- Location
- Aurora, CO + 15 other US sites
- Eligibility basics
- Ages 1 mo–18
- RecruitingPhase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Novartis Pharmaceuticals
- Location
- Aurora, CO + 3 other US sites
- Eligibility basics
- Ages 12–60
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Aurora, CO + 131 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 3
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Novartis Pharmaceuticals
- Location
- Aurora, CO + 21 other US sites
- Eligibility basics
- Ages 12–60
- RecruitingPhase 1
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
Sonoma Biotherapeutics, Inc.
- Location
- Aurora, CO + 8 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Pharming Technologies B.V.
- Location
- Aurora, CO + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Aurora, CO + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 2/Phase 3
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Urovant Sciences GmbH
- Location
- Aurora, CO + 6 other US sites
- Eligibility basics
- Ages 2–17
- Recruiting
The THOR IDE Study
Philips Clinical & Medical Affairs Global
- Location
- Aurora, CO + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Aurora, CO + 34 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Use of CereGate Therapy for Freezing of Gait in PD
CereGate Inc.
- Location
- Aurora, CO + 6 other US sites
- Eligibility basics
- Ages 21–80
- Recruiting
Transdermal Compress IDE Study
Balmoral Medical company
- Location
- Aurora, CO + 8 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 2
DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
Direct Biologics, LLC
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
argenx
- Location
- Aurora, CO + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Zucara Therapeutics Inc.
- Location
- Aurora, CO + 36 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Merck Sharp & Dohme LLC
- Location
- Aurora, CO + 8 other US sites
- Eligibility basics
- Ages 1–17